First floorNews fedaiisf

Emilia Romagna region. ISF regulation. Report of the meeting of 21 October

On 21 October, the meeting of the Working Group on Scientific Information in the context of the SSR was held at the headquarters of the Emilia Romagna Region coordinated by Dr. Valentina Solfrini, Manager of the Pharmaceuticals and Medical Devices Area of the General Management of Care of the Person, Health and Welfare of the Health Policies Department of the Emilia Romagna Region.

It is necessary to underline the active role of Fedaiisf whose action was fundamental in highlighting the application critical issues of the DGR 2309/2016 on the regulation of scientific information, a regulation that would have been dangerous for the future of our work as ISFs

Thanks to the Fedaiisf contribution, the system will be improved and brought closer to working reality.

Fedaiisf was present in the working group representing the Pharmaceutical Representatives (ISF), whose code of ethics is recognized by the Region as a value. ISF was also present for the trade union representatives.

During the meeting, a single regional application was thought of which provides for the insertion of personal data, of the subject matter, of the professional/s that one/they want to meet. It is also expected to happen meeting/s by the informant, with the possibility and not the obligation on the part of the doctor to see at any time whoever wants to meet him (and decline in the case) and who says he has met him (and deny in the case). All of this will weigh neither on the doctor's operations, who can consult the portal if he wants to see whoever wants to see him and, possibly, reschedule the meeting, nor on the operations and managerial autonomy of the IS/ISF which must, a posteriori, indicate which doctor did you see, where and when.

It is important to underline the fact that this portal will be valid for the whole region and is expected to come into operation in the first months of 2020.

We consider the outcome of the meeting to be positive and have parted ways with the commitment that the Working Group will meet again by mid-November to evaluate together and possibly approve a document that addresses the technical and practical provisions of the DGR 2309/2016 that better clarify the aspects of meeting management both at a territorial level (GPs, PLS, health houses) and at the hospital level.

We report the report of the meeting:

Brief report of the meeting Scientific Information Working Group –

October 21, 2019

The first meeting of the WG coordinated by Dr. Solfrini opens with the presentation of the members and their roles.

The objectives of the WG are also presented:

  • identify homogeneous operating methods for the application of the DGR in the individual healthcare companies with the adoption of common tools, possibly electronic but simple to apply;
  • evaluate opportunities and tools to track and enhance information activities on medical devices;
  • share analyzes and proposals relating to the promotion of supplements in public health facilities.

with the intention of developing them in a limited number of meetings.

The work done in the Emilia Romagna Region in recent years on the subject in question is retraced, interrupted in anticipation of an imminent release of new AIFA guidelines which was not implemented. The reconnaissance and comparison work already carried out over the years will form the basis of the 2016 DGR amendment proposals.

It is reiterated that the interest of the region is to guarantee transparency and traceability for the benefit and enhancement of the respective roles and the commitment dedicated to these activities by all the professionals involved, avoiding that the deliberated procedures determine an increase in administrative tasks or avoidable compilers.

The members of the regional part undertake to prepare an easy-to-fill electronic application which will be made available in all companies within the first months of 2020, maintaining the paper filling in the transition period.

It should be remembered that the only figure who has specific rules for defining the role and access is that of the drug scientific representative (Legislative Decree 219/2006), the other figures do not have supporting legislation and could be traced back to the bearers of interest or promoters.

On the subject of Medical devices, it is proposed to distinguish the profile of those who carry out training activities from that of information.

Related news: Emilia-Romagna.dgr-2309-2016

ANAC. Guidelines Code of Conduct SSN. for ISF p. 10 (bottom of page)

Redazione Fedaiisf

Promote the cohesion and union of all members to allow a univocal and homogeneous vision of the professional problems inherent in the activity of pharmaceutical sales reps.

Articoli correlati

Back to top button
Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e del Parafarmaco